Master Class on Translational Immunology in Allergic Diseases (21 – 22 October 2016, Zurich, Switzerland)

Master Class on Translational Immunology in Allergic Diseases
21 – 22 October 2016
Zurich, Switzerland

Organisers: EAACI Immunology Section and the Biologicals Interest Group

In 2016, for the first time, the Immunology Section and the Biologicals Interest Group of EAACI will organise a Master Class on Translational Immunology in Allergic Diseases. State of the art training on novel therapies and current unmet needs in allergic disorders will be addressed. Participants will receive the knowledge and training required to effectively use these immunological tools in the clinic. 

The Master Class will be held over two days and will include plenary style lectures, coupled with interactive case discussion sessions.

During the first day, leading experts in the field will provide comprehensive updates on how to identify phenotypes and immunological endotypes in patients suffering from asthma, allergic rhinitis, atopic dermatitis, urticaria, food allergy, eosinophilic esophagitis and those patients undergoing immunotherapy. The basic immunological mechanisms underpinning these clinical phenotypes and endotypes will also be discussed.

During the second day, there will be detailed clinical presentations on the use of anti-IgE, anti-IL-5, anti-IL-4 and anti-IL-13 in the clinic. Specifically, participants will learn how and when to use these biologics, how to prevent, recognise and manage side-effects and how to treat difficult patients. Interactive sessions involving case presentations by faculty and participants will ensure that the new knowledge can be applied in a real world setting. Finally, novel immune targets and microbiome targets currently in development and clinical trials for allergy and asthma patients will be discussed.

Click below to access the scientific programme:

Target Audience
Whereas EAACI’s Allergy Schools are tailored for more junior attendees, the Master Class requires a higher level of professional experience and offers an excellent platform for exchange of knowledge. However, age is not a criterion for exclusion.
The target audience is specialised clinicians working in the fields of allergy and asthma who want to know more about the link between clinical presentation and treatment options with biologics based on endotyping.

CME Accreditation
This Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS) in cooperation with the European Board of Accreditation in Allergy and Clinical Immunology (EBAACI) to provide the following CME activity for medical specialists. The Congress has been designated for 9 hours of European external CME credits (ECMECs).*

SSAI accreditation
The Swiss Society for Allergology and Immunology (SSAI) has evaluated this event. The programme of the event has been accepted as valid for continuous medical education and is accredited with 12 credits SSAI.  

Submission of case reports
This Master Class will have an interactive session in which difficult cases submitted by attendees will be discussed. Please contact EAACI HQ at for further information if you would like to discuss a case.

Master Class Venue
The Master Class will take place in the Sheraton Zurich Hotel.

Sheraton Zurich Hotel
Pfingstweidstrasse 100
8005 Zurich
Tel: +41 44 285 40 00

The EAACI Master Class on Translational Immunology in Allergic Diseases has reached the maximum capacity and registration is now closed.

Registration Fees
Early bird registration fees until 19 August 2016:
EAACI Member* / EAACI Junior Member EUR 500.00
Non-Member EUR 800.00

Registration fee after 19 August 2016:
EAACI Member* / EAACI Junior Member EUR 600.00
Non-Member EUR 900.00

*Only EAACI Members who have paid the full amount of their membership fee are entitled to this reduced fee. Please make sure to pay the EAACI membership before you register for this Master Class.

Registration for the Master Class includes:

  • Course material (programme book, speaker handouts)
  • Coffee breaks
  • Welcome reception on Friday
  • Lunch on Saturday

The registration fee does not include travel costs and accommodation.
A promotional code for a recommended hotel will be available shortly and participants are requested to handle their own hotel booking and travel arrangements.

We are looking forward to seeing you in Zurich.

Liam O’Mahony
Chair Immunology Section
Onur Boyman
Chair Biologicals
Interest Group
Peter Schmid-Grendelmeier
Vice President Education and Specialty

*EACCME credits are recognised in Europe and by the American Medical Association (AMA) towards the Physician’s Recognition Award (PRA). In order to convert EACCME credit to AMA PRA category 1 credit, please contact the AMA office for more information. Furthermore, live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback